neostigmine has been researched along with Heart Valve Diseases in 1 studies
Neostigmine: A cholinesterase inhibitor used in the treatment of myasthenia gravis and to reverse the effects of muscle relaxants such as gallamine and tubocurarine. Neostigmine, unlike PHYSOSTIGMINE, does not cross the blood-brain barrier.
neostigmine : A quaternary ammonium ion comprising an anilinium ion core having three methyl substituents on the aniline nitrogen, and a 3-[(dimethylcarbamoyl)oxy] substituent at position 3. It is a parasympathomimetic which acts as a reversible acetylcholinesterase inhibitor.
Heart Valve Diseases: Pathological conditions involving any of the various HEART VALVES and the associated structures (PAPILLARY MUSCLES and CHORDAE TENDINEAE).
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Takeuchi, E | 1 |
Murase, M | 1 |
Tanaka, M | 1 |
Hibi, M | 1 |
Yasuura, K | 1 |
Ogawa, K | 1 |
Hotta, A | 1 |
Saigusa, H | 1 |
Yoshida, K | 1 |
Abe, T | 1 |
1 other study available for neostigmine and Heart Valve Diseases
Article | Year |
---|---|
[Replenishment of Young-GIK cardioplegia under the re-aortic cross clamp].
Topics: Aorta; Citrates; Heart Arrest, Induced; Heart Valve Diseases; Humans; Hypothermia, Induced; Magnesiu | 1986 |